Clinical Trial Update: Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

View source ↗

Summary

This clinical trial update indicates CSL Behring's AAV5-hFIX gene therapy trial for Hemophilia B is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• AAV5-hFIX

Snippet

Sponsor: CSL Behring | Conditions: Hemophilia B | Status: ACTIVE_NOT_RECRUITING